Reproductive assistance in HIV-1 discordant couples

Current Opinion in Obstetrics and Gynecology

Volumn 20, Issue 3, 2008, Pages 205-210

  Savasi, Valeria ^a   Parrilla, Bina ^a   Ratti, Martina ^a   Ferrazzi, Enrico ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Assisted reproductive technique; HIV; Sperm washing

Indexed keywords

CLINICAL PRACTICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFECTION RISK; INFERTILITY THERAPY; MEDICAL ETHICS; MEDICAL SOCIETY; PATIENT SAFETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REPRODUCTION; REVIEW; SEMEN ANALYSIS; SPERM; VIRUS TRANSMISSION;

FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INSEMINATION, ARTIFICIAL; MALE; PREGNANCY; SPERMATOZOA;

EID: 43149083464     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/GCO.0b013e3282ff1217     Document Type: Review

References (60)

1. World Health Organisation (WHO) laboratory manual for the examination of human semen and semen-cervical mucus interaction, 4th ed. Cambridge, UK: Cambridge University Press; 1999.
2. May M, Sterne JA, Sabin C, et al. Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies. AIDS 2007; 21:1185-1197. This is an excellent collaborative analysis of prospective studies: The data from 12 cohorts in Europe and North America on 20 379 adults who started HAART between 1995 and 2003 was analysed.
3. Barroso PF, Schechter M, Gupta P, et al. Effect of antiretroviral therapy on HIV shedding in semen. Ann Intern Med 2000; 15:280-284.
4. Ethics Committee of the American Society for Reproductive Medicine Human immunodeficiency virus and infertility treatment. Fertil Steril 2002; 77: 218-222.
5. De Vincenzi I. A longitudinal study of immunodeficiency virus transmission by heterosexual partners. European Study Group on Heterosexual Transmission of HIV. New Engl J Med 1994; 33:341-346.
6. Downs AM, De Vincenzi I. Probability of heterosexual transmission of HIV: relationship to the number of unprotected sexual contacts. European Study Group in Heterosexual Transmission of HIV. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 11:388-395.
7. Mandelbrot L, Heard I, Henrion-Geant E, et al. Natural conception in HIV-negative women with HIV-infected partners. Lancet 1997; 349:850-851.
8. Padian NS, Shiboski SC, Glass SO, et al. Heterosexual transmission of human immunodeficiency virus (HIV) in northern California: results from a ten-year study. Am J Epidemiol 1997; 146:350-357.
9. Pena JE, Thornton MH II, Sauer MV. Assessing the clinical utility of in vitro fertilization with intracytoplasmic sperm injection in human immunodeficiency virus type 1 serodiscordant couples: report of 113 consecutive cycles. Fertil Steril 2003; 80:356-362.
10. Englert Y, Van Vooren JP, Place I, et al. ART in HIV-infected couples. Hum Reprod 2001; 16:1309-1315.
11. Araneta MR, Mascola L, Eller A, et al. HIV transmission through donor artificial insemination. J Am Med Assoc 1995; 273:854-858.
12. Matz B, Kupfer B, Ko Y, et al. HIV-1 infection by artificial insemination. Lancet 1998; 351:728.
13. Baccetti B, Benedetto A, Burrini AG, et al. HIV-particles in spermatozoa of patients with AIDS and their transfer into the oocyte. J Cell Biol 1994; 127:903-914.
14. Brogi A, Presentini R, Moretti E, et al. New insights into the interaction between the gp120 and the HIV receptor in human sperm. J Reprod Immunol 1998; 41:213-231.
15. Lasheeb AS, King J, Ball JK, et al. Semen characteristics in HIV-1 positive men and the effect of semen washing. Genitourin Med 1997; 73:303-305.
16. Quayle AJ, Xu C, Mayer KH, et al. T lymphocytes and macrophages, but not motile spermatozoa are a significant source of human immunodeficiency virus in semen. J Infect Dis 1997; 176:960-968.
17. Pudney J, Nguyen H, Xu C, et al. Microscopic evidence against HIV-1 infection of germ cells or attachment to sperm. J Reprod Immunol 1998; 4:105-125.
18. Semprini AE, Levi-Setti P, Bozzo M, et al. Insemination of HIV-negative women with processed semen of HIV-positive partners. Lancet 1992; 28:1317-1319.
19. Borzy MS, Connell RS, Kiessling AA. Detection of human immunodeficiency virus in cell-free seminal fluid. J Acquir Immune Defic Syndr 1988; 1:419-424.
20. Bujan L, Pasquier C, Labeyrie E, et al. Insemination with isolated and virologically tested spermatozoa is a safe way for human immunodeficiency type 1 virus-serodiscordant couples with an infected male partner to have a child. Fertil Steril 2004; 82:857-862.
21. Bagasra O, Freund M, Weidmann J, et al. Interaction of human immunodeficiency virus with human sperm in vitro. J Acquir Immune Defic Syndr 1988; 1:431-435.
22. Bagasra O. Presence of HIV-1 in sperm of patients with HIV-1/AIDS. Mol Androl 1990; 2:109-125.
23. Bagasra O, Farzadegan H, Seshamma T, et al. Detection of HIV-1 proviral DNA in sperm from HIV-1 infected men. AIDS 1994; 8:1669-1674.
24. Anderson DJ, et al. Presence of HIV-1 in semen. In: Alexander NJ, Gabelnick HL, Spieler JM, editors. Heterosexual transmission of AIDS. Proceedings of the Second Contraceptive Research and Development (CONRAD) Program International Workshop, Held in Norfolk, Virginia, February 1-3, 1989. Wiley-Liss, New York, 1990; 167-180.
25. Baccetti B, Benedetto A, Burrini AG, et al. HIV particles detected in spermatozoa of patients with AIDS. J Submicrosc Cytol Pathol 1991; 23:339-345.
26. Baccetti B, Benedetto A, Collodel G, et al. The debate on the presence of HIV-1 in human gametes. J Reprod Immunol 1998; 41:41-67.
27. Gobert B, Amiel C, Tang JQ, et al. CD4-like molecules in human sperm. FEBS Lett 1990; 261:339-342.
28. Miller VE, Scofield VL. Transfer of HIV-1 by semen: role of sperm. In Alexander NJ, Gabelnick HL, Spieler JM, editors. Heterosexual transmission of AIDS. Proceedings of the Second Contraceptive Research and Development (CONRAD) Program International Workshop, Held in Norfolk, Virginia, February 1-3, 1989. Wiley-Liss, New York, 1990; 147-154.
29. Pudney J. Caveats associated with identifying HIV-1 using transmission electron microscopy. In Alexander NJ, Gabelnick HL, Spieler JM, editors. Heterosexual transmission of AIDS. Proceedings of the Second Contraceptive Research and Development (CONRAD) Program International Workshop, Held in Norfolk, Virginia, February 1-3, 1989. Wiley-Liss, New York, 1990; 197-204.
30. Mermin JH, Holodniy M, Katzenstein DA, et al. Detection of human immunodeficiency virus DNA and RNA in semen by the polymerase chain reaction. J Infect Dis 1991; 164:769-772.
31. Van Voorhis BJ, Martinez A, Mayer K, et al. Detection of HIV-1 in semen from seropositive men using culture and polymerase chain detection deoxyribonucleic acid amplification techniques. Fertil Steril 1991; 55:588-594.
32. Scofield VL, Rao B, Broder S, et al. HIV interaction with sperm. AIDS 1994; 8:1733-1736.
33. Dussaix E, Guetard D, Dauget C, et al. Spermatozoa as potential carriers of HIV-1. Res Virol 1993; 144:487-495.
34. Nuovo GJ, Becker J, Simsir A, et al. HIV-1 nucleic acids localize to the spermatogonia and their progeny. A study by polymerase chain reaction in situ hybridization. Am J Pathol 1994; 144:1142-1148.
35. Muciaccia B, Uccini S, Filippini A, et al. Presence and cellular distribution of HIV-1 in the testes of seropositive subjects: an evaluation by in situ PCR hybrydization. FASEB J 1998; 12:151-163.
36. Shevchuk MM, Nuovo GJ, Khalife G. HIV-1 in testis: quantitative histology and HIV-1 localization in germ cells. J Reprod Immunol 1998; 41:69-79.
37. Ohl J, Partisani M, Wittemer C, et al. Assisted reproduction techniques for HIV serodiscordant couples: 18 months of experience. Hum Reprod 2003; 18:1244-1249.
38. Garrido N, Meseguer M, Bellver J, et al. A report of the results of a 2 year programme of sperm wash and ICSI treatment human immunodeficiency virus and hepatitis C virus serodiscordant couples. Hum Reprod 2004; 19:2581-2586.
39. Politch JA, Xu C, Tucker L, Anderson DJ. Separation of human immunodeficiency virus type 1 from motile sperm by the double tube gradient method versus other methods. Fertil Steril 2004; 81:440-447.
40. Marina S, Marina F, Alcolea R, et al. Human immunodeficiency virus type 1-serodiscordant couples can bear healthy children after undergoing intra-uterine insemination. Fertil Steril 1998; 70:35-39.
41. Garrido N, Meseguer M, Bellver J. In-vitro fertilization with intracytoplasmic sperm injection for human immunodeficiency virus-1 serodiscordant couples. Am J Obstet Gynecol 2002; 187:1121.
42. Meseguer M, Garrido N, Gimeno C, et al. Comparison of polymerase chain reaction-dependent methods for determining the presence of human immunodeficiency virus and hepatitis C virus in washed sperm. Fertil Steril 2002; 78:1199-1202.
43. Leruez-Ville M, de Almeida M, Tachet A, et al. Assisted reproduction in HIV-1-serodifferent couples: the need for viral validation of processed semen. AIDS 2002; 16:2267-2273.
44. Xu C, Politch JA, Mayer KH, Anderson DJ. Human immunodeficiency virus type-1 episomal cDNA in semen. AIDS Res Ther 2005; 2:9.
45. Decree of May 10 (2001). Prise en charge en assistance médicale à la procréation des patients à risque viral. Page 7735. Arrêté du 10 mai 2001. Journal Officiel de la République Française, 15 mai 2001.
46. Sauer MV. Sperm washing techniques address the fertility needs of HIV-seropositive men: a clinical review. Reprod Biomed Online 2005; 1:135-140.
47. Gilling-Smith C. Assisted reproduction in HIV-discordant couples. AIDS Read 2000; 10:581-587.
48. Nicopoullos JD, Almeida PA, Ramsay JWA, Gilling-Smith C. The effect of human immunodeficiency virus on sperm parameters and the outcome of intrauterine insemination following sperm washing. Hum Reprod 2004; 19:2289-2297.
49. Hanabusa H, Kuji N, Kato S, et al. An evaluation of semen processing methods for eliminating HIV-1. AIDS 2000; 14:1611-1616.
50. Persico T, Savasi V, Ferrazzi E, et al. Detection of human immunodeficiency virus-1 RNA and DNA by extractive and in situ PCR in unprocessed semen and seminal fractions isolated by semen-washing procedure. Hum Reprod 2006; 21:1525-1530.
51. Barreiro P. Benefit of antiretroviral therapy for serodiscordant couples willing to be parents. Late breakers Seventh International Congress on Drug Therapy in HIV Infection, 14-18 November, Abstract number 2004; PL13.3, Glasgow, Scotland.
52. Klein J, Pena JE, Thornton MH, Sauer MV. Understanding the motivations, concerns, and desires of human immunodeficiency virus 1-serodiscordant couples wishing to have children through assisted reproduction. Obstet Gynecol 2003; 101:987-994.
53. ESHRE. Assisted reproductive technology in Europe, 2002. Results generated from European registers by ESHRE. Hum Reprod 2006; 21:1680-1697.
54. Pena JE, Thornton MH, Sauer MV. Assessing the clinical utility of in vitro fertilization with intracytoplasmic sperm injection in human immunodeficiency virus type 1 serodiscordant couples: report of 113 consecutive cycles. Fertil Steril 2003; 80:356-362.
55. Nakhuda GS, Sauer MV. Addressing the growing problem of multiple gestations created by assisted reproductive therapies. Semin Perinatol 2005; 29:355-362.
56. Oliviennes F. Double trouble: yes a twin pregnancy is an adverse outcome. Hum Reprod 2000; 15:1663-1665.
57. Garrido N, Remohí J, Pellicer A, Meseguer M. The effectiveness of modified sperm washes in severely oligoasthenozoospermic men infected with human immunodeficiency and hepatitis C viruses. Fertil Steril 2006; 86:1544-1546.
58. Garrido N, Meseguer M. Use of washed sperm for assisted reproduction in HIV-positive males without checking viral absence. A risky business? Hum Reprod 2006; 21:567-568. (Letter).
59. Piomboni P, Mencaglia L, De Leo V. Reply to: use of washed sperm for assisted reproduction in HIV-positive males without checking viral absence. A risky business? Hum Reprod 2006; 21:568. (Letter).
60. Bujan L, Hollander L, Coudert M, et al., CREAThE network. Safety and efficacy of sperm washing in HIV-1-serodiscordant couples where the male is infected: results from the European CREAThE network. AIDS 2007; 12:1909-1914. This first multicentre retrospective study of assisted reproduction following sperm washing demonstrates the method to be effective and to significantly reduce HIV-1 transmission risk to the uninfected female partner.